In recent years, the specialty pharmacy industry has been defined by rapid growth with considerable entry from new participants. Factors driving growth include an increase of therapies introduced into the pharmacy benefit class rather than through the medical benefit, a growing number of patients receiving treatment for a wider range of conditions, price inflation caused
Every year, Canadians, who have access to one of the most advanced health care systems in the world, spend more than $200 billion on health care, $34 billion of which is on pharmaceuticals. Although medical services are socialized, government-supported drug benefits are limited to children, the elderly and the poor. In this regard, drug funding
Personalized medicine is broadly defined as the individual customization of health care — medical decisions, practices or treatment. For the community pharmacy industry, the impact of this trend is an over-the-horizon disruptor that will impact, among other things, the work flow in the retail pharmacy, the expectations of the pharmacists and the industry operating model.